262 related articles for article (PubMed ID: 16440801)
21. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine.
Zák P; Chrobák L; Podzimek K; Plísková L; Dedic K
Neoplasma; 1998; 45(4):261-5. PubMed ID: 9890671
[TBL] [Abstract][Full Text] [Related]
22. [Successful treatment of hairy cell leukemia with pentostatin].
Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
[TBL] [Abstract][Full Text] [Related]
23. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.
Juliusson G; Heldal D; Hippe E; Hedenus M; Malm C; Wallman K; Stolt CM; Evensen SA; Albertioni F; Tjønnfjord G
J Clin Oncol; 1995 Apr; 13(4):989-95. PubMed ID: 7707128
[TBL] [Abstract][Full Text] [Related]
24. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
Urasiński I; Zdziarska B; Krygier-Stojałowska A
Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
[TBL] [Abstract][Full Text] [Related]
25. Hairy cell leukaemia with advanced treatment - a case report.
Momen A; Sarker CB; Siddiqui NI; Huq MH; Jamal MF; Talukder SI; Rahman KM
Mymensingh Med J; 2003 Jul; 12(2):134-7. PubMed ID: 12894049
[TBL] [Abstract][Full Text] [Related]
26. [Hairy cell leukemia successfully treated with deoxycoformycin].
Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
[TBL] [Abstract][Full Text] [Related]
27. Phase II clinical study of cladribine in the treatment of hairy cell leukemia.
Machii T; Chou T; Suzuki M; Ohe Y; Katagiri S; Kitano EK; Kitano K; Fujiyama Y; Izumi T; Shimazaki C; Nanba K; Ohashi Y; Kitani T;
Int J Hematol; 2005 Oct; 82(3):230-5. PubMed ID: 16207596
[TBL] [Abstract][Full Text] [Related]
28. [Hairy cell leukemia in young patients].
Al'-Radi LS; Samoĭlova RS; Tikhonova LIu; Diagileva OA; Naumova IN; Kaplanskaia IB; Varlamova EIu
Ter Arkh; 2008; 80(12):53-8. PubMed ID: 19227908
[TBL] [Abstract][Full Text] [Related]
29. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
Dedic K; Zák P
Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
[TBL] [Abstract][Full Text] [Related]
30. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia.
Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T
Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414
[No Abstract] [Full Text] [Related]
31. [Successful rituximab treatment in a patient with refractory hairy cell leukemia-Japanese variant and suffering from acute respiratory distress].
Makita M; Nakamura K; Kono A
Rinsho Ketsueki; 2005 Nov; 46(11):1196-201. PubMed ID: 16440803
[TBL] [Abstract][Full Text] [Related]
32. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient.
Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F
Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).
Zenhäusern R; Schmitz SF; Solenthaler M; Heim D; Meyer-Monard S; Hess U; Leoncini L; Bargetzi M; Rufener B; Tobler A
Leuk Lymphoma; 2009 Sep; 50(9):1501-11. PubMed ID: 19672771
[TBL] [Abstract][Full Text] [Related]
34. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
von Rohr A; Schmitz SF; Tichelli A; Hess U; Piguet D; Wernli M; Frickhofen N; Konwalinka G; Zulian G; Ghielmini M; Rufener B; Racine C; Fey MF; Cerny T; Betticher D; Tobler A;
Ann Oncol; 2002 Oct; 13(10):1641-9. PubMed ID: 12377655
[TBL] [Abstract][Full Text] [Related]
35. Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia.
Tadmor T; Levy I; Herishanu Y; Goldschmidt N; Bairey O; Yuklea M; Shvidel L; Fineman R; Aviv A; Ruchlemer R; Braester A; Dally N; Rouvio O; Shaulov A; Greenbaum U; Inbar M; Polliack A
Leuk Res; 2019 Jul; 82():24-28. PubMed ID: 31152919
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y
Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268
[TBL] [Abstract][Full Text] [Related]
37. [Complete remission after Rituximab treatment in refractory hairy cell leukemia].
Petruskevicius I; Bukh A; Mertz H; Johnsen HE
Ugeskr Laeger; 2008 Jun; 170(26-32):2350. PubMed ID: 18570771
[TBL] [Abstract][Full Text] [Related]
38. Treatment of hairy cell leukemia-variant with cladribine.
Tetreault SA; Robbins BA; Saven A
Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
[TBL] [Abstract][Full Text] [Related]
39. Hairy cell leukemia: clinical presentation and long term follow up after treatment with 2-chlorodeoxyadenosine (2-CdA).
Bilwani F; Usman M; Adil SN; Kakepoto GN; Khurshid M
J Pak Med Assoc; 2005 May; 55(5):212-3. PubMed ID: 15960289
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.
Hoffman MA; Janson D; Rose E; Rai KR
J Clin Oncol; 1997 Mar; 15(3):1138-42. PubMed ID: 9060556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
